Rituximab Response Patterns: Podocytopathies Compared with Membranous Nephropathy (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0816; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Conclusion The reduction in proteinuria following RTX infusion appears to be more rapid in FSGS/MCD with major proportion of complete remission than in MN after 6m, although no difference between proteinuria levels and complete remission was detected after 1 year. The initial differences in response between diseases help clinicians predict the timing of therapeutic effects of RTX."
Chronic Kidney Disease • Focal Segmental Glomerulosclerosis • Glomerulonephritis • Nephrology • Renal Disease
|
|
Ana Laura Pereira Moura; Julia Mello Lucena; Barbhara Thaís Maciel Pontes; Gessica Sabrine Braga Barbosa; Marcio Dantas
|